Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 20, 2025

Study Completion Date

December 20, 2025

Conditions
ObesityPostoperative PainBariatric Surgery
Interventions
DRUG

Dexmedetomidine infusion

A bolus dose of dexmedetomidine (0.5 µg/kg ideal body weight) diluted in 0.9% normal saline is infused over 10 minutes before induction of anesthesia, followed by a continuous infusion at 0.5 µg/kg/h until 10 minutes before the end of surgery.

DRUG

Ketamine infusion

A bolus dose of ketamine (0.3 mg/kg ideal body weight) diluted in 0.9% normal saline is infused over 10 minutes before induction of anesthesia, followed by a continuous infusion at 0.3 mg/kg/h until 10 minutes before the end of surgery.

DRUG

Normal Saline Infusion (Placebo)

A bolus dose of 0.9% normal saline is infused over 10 minutes before induction of anesthesia, followed by a continuous infusion of 0.9% normal saline until 10 minutes before the end of surgery.

All Listed Sponsors
lead

Tanta University

OTHER

NCT06738043 - Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery | Biotech Hunter | Biotech Hunter